Dominic Piscitelli is an independent director at Celyad. Dominic was previously the Chief Financial Officer at AnaptysBio from January 2017 to September 2019. Prior to that, they were the Vice President of Finance, Strategy and Investor Relations at Medivation from January 2012 to January 2017. Dominic also has experience as the Senior Director of Global Finance at Astellas Pharma from January 2011 to December 2012. Dominic began their career as an Audit Manager at KPMG Audit from January 1996 to December 2001 before becoming the Vice President of Treasury and Management Finance at OSI Pharmaceuticals from September 2001 to December 2011.
Dominic Piscitelli received their master's degree in accounting and finance from Hofstra University.